IDT Biologika
Dedicated to Contract Development and Manufacturing of
Viral Vaccines, Viral Vectors and Biologics

IDT Biologika specializes in the contract development and manufacturing of Viral Vaccines, Gene and Immunotherapeutics as well as sterile liquids and lyophilized Biologics. We help biopharmaceutical and biotech companies as well as the US government as part of research consortia with the challenging and complex process of translating viral vaccines and biopharmaceuticals from the research lab through clinical development to large-scale commercial manufacturing including drug substance production, fill & finish, packaging and analytics. IDT Biologika provides fully integrated services for GMP compliant end-to-end services in BSL2 facilities meeting EMA, FDA and ANVISA standards.

We strive for strong, trusting and enduring customer partnerships. Our almost 100 year tradition in manufacturing vaccines and biopharmaceuticals motivates and obligates us to advance our clients’ products to prevent and treat diseases that impact the health of people worldwide.

Our Awards

CMO Leadership Award

2020

PharmaTech Outlook

2020

Focus Innovation Award

2020

Twitter
@IDT Biologika

Wednesday, 14. October 2020

We are happy to be part of World Vaccine Congress (Europe). Join us at the virtual event next week, from Oct 19 – 2… https://t.co/SyYPXbGg3h more info

Thursday, 8. October 2020

The partners of the @DZIF_ and IDT have reached a further milestone in the development of a #vaccine against… https://t.co/TCsP69J4hc more info

Thursday, 8. October 2020

RT @DZIF_: Das @PEI_Germany hat die klinische Prüfung mit dem Impfstoff #MVA-SARS-2-S gegen #COVID-19 genehmigt. Der Impfstoff wurde von Fo… more info

Friday, 2. October 2020

The @PEI_Germany has approved clinical testing with the vaccine MVA-SARS-2-S against #COVID19. The vector vaccine w… https://t.co/kQQO30IGOD more info

Monday, 21. September 2020

RT @pharmaphorum: .@BioNTech_Group and @CureVacRNA claim bulk of Germany’s €750m #COVID19 vaccines funding pie, with @idtbiologika also in… more info

Monday, 21. September 2020

RT @AllemagneDiplo: #Covid_19 | Le gouvernement 🇩🇪 va soutenir les laboratoires @BioNTech_Group, @CureVacRNA et @idtbiologika à hauteur de… more info

Wednesday, 9. September 2020

As a contract manufacturer of #vaccines and gene and immune therapy products, IDT Biologika also offers GMP complia… https://t.co/Zp5iCuepVG more info

Saturday, 15. August 2020

Our facility in Rockville, MD, USA has broad capabilities and a depth of technologies in process development and pr… https://t.co/fpu0EO4RRJ more info

Friday, 14. August 2020

RT @DonorTracker: The 🇩🇪German Ministry of Education and Research (@BMBF_Bund) has provided funding grants to three biotech companies – #Cu… more info

IDT Biologika receives official notification of funding from the Federal government

Thursday, 8. October 2020

IDT Biologika receives official notification of funding from the Federal government more info

SARS-CoV-2: IDT Biologika fills vaccine candidate

Wednesday, 29. July 2020

Clinical phase about to begin more info

Deputy leader of the parliamentary FDP visits IDT Biologika

Friday, 10. July 2020

Battle against SARS-CoV-2 at the heart of Germany more info

Positive interim summary of strategic realignment at CPhl trade fair:

Tuesday, 5. November 2019

IDT Biologika expands portfolio of viral vaccines and biologics more info

IDT Biologika Awarded new Task Order to Manufacture Vaccines and Biologics for Infectious Diseases

Monday, 4. November 2019

IDT Biologika Awarded new Task Order in the Scope of 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases more info